Insmed Inc
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 21.1% | 22.0% | 23.1% | 23.2% | 22.7% | 25.0% | 22.9% | 26.1% | 20.6% | 16.8% | 16.2% | 15.8% | 16.7% | |
| 78.9% | 78.0% | 76.9% | 76.8% | 77.3% | 75.0% | 77.1% | 73.9% | 79.4% | 83.2% | 83.8% | 84.2% | 83.3% | |
| 138.0% | 163.7% | 160.4% | 162.4% | 161.4% | 172.1% | 164.4% | 165.0% | 131.0% | 96.6% | 68.5% | 49.4% | 75.7% | |
| 114.6% | 107.0% | 123.3% | 118.0% | 127.3% | 136.5% | 159.0% | 144.1% | 130.9% | 80.5% | 80.8% | 58.2% | 78.5% | |
| 265.6% | 291.0% | 269.6% | 396.6% | 305.8% | 295.6% | 344.4% | 365.1% | 336.5% | 177.9% | 149.3% | 84.6% | 155.1% | |
| -186.8% | -213.0% | -192.7% | -319.8% | -228.4% | -220.6% | -267.3% | -291.3% | -257.1% | -94.6% | -65.5% | -0.4% | -71.9% | |
| 25.7% | 24.8% | 27.9% | 23.5% | 22.5% | 20.6% | 23.2% | 19.8% | 14.3% | 7.8% | 6.6% | 4.8% | 7.1% | |
| -200.3% | -221.1% | -207.3% | -331.8% | -235.0% | -224.3% | -275.4% | -298.3% | -259.0% | -123.9% | -53.0% | -2.7% | -76.4% | |
| 0.7% | 1.2% | 0.8% | 0.9% | 1.1% | 1.2% | 1.0% | 1.2% | 0.9% | 0.6% | 0.5% | 0.4% | 0.5% | |
| -201.0% | -222.3% | -208.1% | -332.8% | -236.0% | -225.5% | -276.4% | -299.5% | -260.0% | -124.5% | -53.5% | -3.1% | -76.9% | |
| -172.7% | -194.2% | -177.1% | -306.5% | -210.3% | -202.7% | -250.8% | -276.6% | -242.8% | -114.5% | -44.6% | 3.3% | -67.7% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.